K. Bross

2.5k total citations
62 papers, 1.9k citations indexed

About

K. Bross is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, K. Bross has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in K. Bross's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). K. Bross is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). K. Bross collaborates with scholars based in Germany, United States and Canada. K. Bross's co-authors include Ulrich Costabel, H Matthys, Reinhard Andreesen, W. Krone, Karl G. Blume, Albrecht Reichle, G. W. Löhr, Wayne E. Spruce, G. W. Löhr and Gerassimos A. Pangalis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

K. Bross

59 papers receiving 1.8k citations

Peers

Countries citing papers authored by K. Bross

Since Specialization

Citations

This map shows the geographic impact of K. Bross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Bross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Bross more than expected).

Fields of papers citing papers by K. Bross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Bross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Bross. The network helps show where K. Bross may publish in the future.

Co-authorship network of co-authors of K. Bross

This figure shows the co-authorship network connecting the top 25 collaborators of K. Bross. A scholar is included among the top collaborators of K. Bross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Bross. K. Bross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ia-like Antigens on T-Cells and Their Subpopulations in Pulmonary Sarcoidosis and in Hypersensitivity Pneumonitis 2015 ·American Review of Respiratory Disease ·Ulrich Costabel, K. Bross, K.-H. Rühle, G. W. Löhr, H Matthys	0
2	Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial 2011 ·Medical Oncology ·Bernhard Walter, (unknown), Martin Vogelhuber, Jochen Grassinger, K. Bross, Jochen Wilke, T. Suedhoff, Anna Berand, W.F. Wieland, Sebastian Rogenhofer, Reinhard Andreesen, Albrecht Reichle	25
3	Symptomatische leukämische Infiltration der Lunge als Komplikation einer akuten myeloischen Leukämie 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Norbert Meidenbauer, Gudrun Schlake, K. Bross, Reinhard Andreesen	1
4	Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma 2004 ·Cancer ·Albrecht Reichle, K. Bross, Thomas Vogt, Frauke Bataille, Peter J. Wild, Anna Berand, Stefan W. Krause, Reinhard Andreesen	73
5	Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors 2003 ·Cancer ·Thomas Vogt, Christian Hafner, K. Bross, Frauke Bataille, Karl‐Walter Jauch, Anna Berand, Michael Landthaler, Reinhard Andreesen, Albrecht Reichle	116
6	In vivo labelling of the spleen with a red-fluorescent cell dye 1993 ·Journal of Immunological Methods ·(unknown), Guido Wolff-Vorbeck, K. Bross, L. Kerp, (unknown)	11
7	Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase? in human tumour lines: implications for in vitro chemoresistance 1992 ·Journal of Cancer Research and Clinical Oncology ·Thomas Licht, K. Bross, Heinz‐Herbert Fiebig, (unknown), Dietmar Berger, (unknown), (unknown), F. Herrmann	4
8	Unusual Sequence of Immunoglobulin L‐Chain Rearrangements in a Gamma Heavy Chain Disease Patient 1992 ·Scandinavian Journal of Immunology ·(unknown), E. Schiltz, K. Bross, (unknown), H. H. Peter, Ulrich Krawinkel	4
9	Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. 1992 ·PubMed ·Hans‐Jürgen Gruss, Marion A. Brach, (unknown), K. Bross, F. Herrmann	69
10	Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with β-lactams and aminoglycosides 1991 ·Infection ·A. A. Fauser, Gottfried Dölken, K. Bross, (unknown), Eva Lang, F. Sörgel	10
11	Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay 1991 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Peter Deibert, Harris Busch, G. W. Löhr, K. Bross	4
12	Combination of cytokines: current status and future prospects 1991 ·British Journal of Haematology ·Lothar Kanz, Wolfram Brugger, K. Bross, Roland Mertelsmann	6
13	Induction of multiple‐drug resistance during anti‐neoplastic chemotherapy in vitro 1991 ·International Journal of Cancer ·Thomas Licht, Heinz‐Herbert Fiebig, K. Bross, F. Herrmann, Dietmar Berger, Robert H. Shoemaker, Roland Mertelsmann	43
14	Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte‐rich effusions 1989 ·Diagnostic Cytopathology ·Josune Guzman, K. Bross, (unknown), Nikolaus Freudenberg, Ulrich Costabel	9
15	Immunocytology in Malignant Pleural Mesothelioma 1989 ·CHEST Journal ·Josune Guzman, K. Bross, (unknown), Ulrich Costabel	17
16	Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies. 1985 ·BMJ ·Ulrich Costabel, K. Bross, H Matthys	22
17	Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes 1984 ·Annals of Hematology ·Reinhard Andreesen, (unknown), H. H. Bodemann, K. Bross, Ulrich Costabel, (unknown)	101
18	Immunoglobulin light chains in chronic lymphocytic leukemia and related diseases 1984 ·Annals of Hematology ·(unknown), (unknown), K. Bross, (unknown), (unknown), (unknown)	1
19	The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipients 1979 ·Annals of Hematology ·GM Schmidt, Karl G. Blume, K. Bross, Wayne E. Spruce, (unknown), (unknown)	4
20	A highly sensitive peroxidase-antiperoxidase method for detection of H-Y antigen on cultivated human fibroblasts 1979 ·Human Genetics ·U. M�ller, K. Bross	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact